ArticleTargeted oncology2018

The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study.

Lotte M Knapen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.